Camp4 Therapeutics (CAMP) Invested Capital: 2023-2025
Historic Invested Capital for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $58.7 million.
- Camp4 Therapeutics' Invested Capital rose 136.95% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 136.95%. This contributed to the annual value of $63.3 million for FY2024, which is 151.16% up from last year.
- According to the latest figures from Q3 2025, Camp4 Therapeutics' Invested Capital is $58.7 million, which was up 46.59% from $40.1 million recorded in Q2 2025.
- Camp4 Therapeutics' 5-year Invested Capital high stood at $63.3 million for Q4 2024, and its period low was -$159.0 million during Q3 2024.
- In the last 3 years, Camp4 Therapeutics' Invested Capital had a median value of $40.1 million in 2025 and averaged -$25.8 million.
- Over the last 5 years, Camp4 Therapeutics' Invested Capital had its largest YoY gain of 151.16% in 2024, and its largest YoY loss of 42.51% in 2024.
- Quarterly analysis of 3 years shows Camp4 Therapeutics' Invested Capital stood at -$123.7 million in 2023, then spiked by 151.16% to $63.3 million in 2024, then skyrocketed by 136.95% to $58.7 million in 2025.
- Its Invested Capital was $58.7 million in Q3 2025, compared to $40.1 million in Q2 2025 and $51.7 million in Q1 2025.